For Health Care Professionals
Outside the U.S. Only
Home « Consequences
Untreated chronic iron overload causes progressive damage to the liver, heart, and endocrine glands, and may eventually lead to premature death. Furthermore, non-specific early symptoms (such as abdominal discomfort and fatigue) may delay diagnosis until severe damage to heart or liver tissues produces clinically apparent symptoms. Therefore at-risk patients (such as those who have received multiple blood transfusions or who have a family history of iron metabolic disorders) should be screened for iron overload.
The consequences of iron deposition appear to vary in different body tissues. In the heart or liver, hemosiderotic injury can eventually be fatal. In the skin, advanced hemosiderosis produces a characteristic — but benign — bronze pigmentation.
In both primary
and secondary iron overload, serum
ferritin >1000 mcg/L
is associated with worsened prognosis.
Click on the diagram below to learn about the potential effects of iron deposition in specific organs and glands.
Whether primary or secondary, severe iron overload is associated with premature death (1).
Among patients with sickle cell disease, iron overload is among the most frequent findings at death, and is associated with the development of cirrhosis and cardiac disease — other leading findings at death in SCD (2).
When iron is bound to transferrin, ferritin, or other iron transport and storage proteins, it cannot participate in oxidative reactions, and therefore cannot cause cellular damage (3). In iron overloaded patients, the capacity of these proteins to neutralize the damaging effects of iron is exceeded. Excess iron binds weakly to various other low-molecular-weight proteins in the plasma and cells, and in this form propagates cellular damage by peroxidation of organelles such as mitochondria, lysosomes, and sarcoplastic membranes.
The most common form of cardiac hemosiderotic injury is congestive cardiomyopathy. Other cardiac pathologies linked to excess iron include pericarditis, angina, and conduction defects.
The main clinical sequelae of excess iron deposition in the liver are fibrosis/cirrhosis and hepatocellular carcinoma. In patients receiving regular transfusions, collagen formation and portal fibrosis can occur within 2 years of the first transfusion (5), while liver cirrhosis can develop within the first decade of life if the excess iron is not removed.
Arthropathy of large joints such as the hips is common in hereditary hemochromatosis (6) — presumably because such damage develops gradually over decades of iron deposition in articular cartilage. Osteoporosis is common among patients with thalassemia (7).
Other troubling musculoskeletal problems include severe muscle cramps and disabling myalgia. Muscle biopsy often reveals iron deposits in the myocytes (8).
Patients with iron overload appear to have increased susceptibility to infections, often with unusual microorganisms (9-11). This apparent immune compromise may result from the abnormally high transferrin saturations seen in patients with iron overload. Transferrin has been shown in vitro to have bacteriostatic properties (12); high saturations may compromise this property.
Cutaneous iron deposition induces melanin production, causing a characteristic bronze pigmentation in fair-skinned people. Exposure to ultraviolet light acts synergistically with this process, and as a result many people with iron overload tan very easily, although these effects are variable. Fair-skinned people seldom develop hyperpigmentation even with a large iron burden, while people of moderate baseline pigmentation often develop a striking almond-colored hue.
Learn more about the most common types of cardiac injury, mechanisms of cardiac iron uptake, assessment of cardiac iron burden, and the association of LIC and serum ferritin with cardiac iron overload.
Learn more about the assessment of hepatic iron burden, the association of liver iron and serum ferritin levels with fibrosis, and factors that may exacerbate liver damage.
References